Processa Pharmaceuticals Ownership | Who Owns Processa Pharmaceuticals?


OverviewForecastFinancialsChart

Processa Pharmaceuticals Ownership Summary


Processa Pharmaceuticals is owned by 4.19% institutional investors, and 95.81% retail investors. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.75% of its assets in Processa Pharmaceuticals shares.

PCSA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockProcessa Pharmaceuticals4.19%-95.81%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders


Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202318-10.00%1,130,700-18.42%415.81%10-9.09%525.00%
Sep 30, 20232011.11%1,386,038-0.25%513.82%11120.00%4-42.86%
Jun 30, 202318-18.18%1,389,520-15.80%611.62%5-58.33%7133.33%
Mar 31, 20232222.22%1,650,24542.14%712.62%1233.33%3200.00%
Dec 31, 202218-1,160,9881.51%715.20%950.00%1-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr24.43K0.75%-
Fidelity Extended Market Index16.81K0.51%-111.00
Fidelity Series Total Market Index4.54K0.14%-215.00
Northern Trust Extended Eq Market Idx1.05K0.03%-
NT Ext Equity Mkt Idx Fd - L1.05K0.03%-
Fidelity Nasdaq Composite Index553.000.02%-
State St US Extended Mkt Indx NL Cl C535.000.02%-
SSgA U.S. Extended Market Index Class I10.70K0.02%-
Fidelity Total Market Index441.000.01%-
Spartan Extended Market Index Pool E429.000.01%111.00

Recent Insider Transactions


DateNameRoleActivityValue
Jan 27, 2025Ng George K Chief Executive OfficerBuy$69.54K
Jan 27, 2025Young David Pres. Research & DevelopmentBuy$99.29K
Jan 27, 2025Lin Patrick Chief Business - Strategy OffBuy$34.69K
Feb 07, 2024Young David Pres. Research & DevelopmentBuy$51.53K
Feb 06, 2024Young David Pres. Research & DevelopmentBuy$50.50K

Insider Transactions Trends


DateBuySell
2024 Q3--
2024 Q16-
2023 Q4--
2023 Q3--
2023 Q25-

PCSA Ownership FAQ


Who Owns Processa Pharmaceuticals?

Processa Pharmaceuticals shareholders are primarily institutional investors at 4.19%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Processa Pharmaceuticals's industry, Biotech Stocks , is 109.70%, which Processa Pharmaceuticals falls below.

Does Blackrock own Processa Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Processa Pharmaceuticals.

Who is the top mutual fund holder of Processa Pharmaceuticals shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Processa Pharmaceuticals shares, with 0.75% of its total shares outstanding invested in 24.43K Processa Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools